ROARABLE
FREE $100K
Today Screener Big Ideas Track Record 💰 $100K Arena 🎲 Predictions 🏛️ Insiders 8 Analysts
Stock Ratings / ETF / Index / ARKK
ITA (47) XLB (67) XBI (65) XLRE (63) ⌘ Pro Terminal →

ARK Innovation ETF (ARKK) — RQD Stock Rating Cockpit

$78.96 -6.46% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $77.89

ARK Innovation ETF (ARKK) earns a Roarable Rating of D+ (Sell) with 53/100 RQD Confidence. As an exchange-traded fund, single-company GAAP gross margins, Altman-Z, and CEO Form 4 insider metrics are N/A for fund structure; its score reflects basket trend, institutional flow, and macro regime alignment.

ROARABLE D+ • SELL / AVOID Cap $6.50B
📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on ARKK Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is ARKK stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼

As of 2026-11-03, ARK Innovation ETF (NYSE: ARKK) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 53/100 at a spot price of $78.96 (-6.46% 1D, market cap $6.50B). Pillar breakdown: Fundamental Cash Engine 16/20, Institutional 13F & Options Flow 9/20, SEC Balance-Sheet Forensics 13/20, FRED Macro Regime Fit 9/20, and Executive Insider Alignment 6/20. Across 40 tracked ETF / Index issuers, ARKK ranks #26 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does ARKK compare to ITA and XLB in the ETF / Index sector?
▼

Within the ETF / Index sector (Disruptive Growth & Biotech), ARKK carries a Roarable D+ (53/100 RQD), trailing P/E of N/A, gross margin of N/A (ETF), and ROIC of N/A (ETF). By comparison, ITA (iShares U.S. Aerospace & Defense ETF) holds a D grade (47/100 RQD, P/E N/A, ROIC —, cap $6.80B) and XLB (Materials Select Sector SPDR Fund) posts a C+ grade (67/100 RQD, P/E N/A, ROIC —, cap $6.00B). Among the 5-stock peer group, ARKK leads on earnings multiple (N/A) while ARKK leads on capital efficiency (— ROIC).

✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for ARKK?
▼

For ARK Innovation ETF (ARKK), key quantitative strengths include Diversified Disruptive Growth & Biotech basket eliminates single-company earnings blowup risk and Deep intraday secondary-market liquidity with transparent underlying index holdings., while primary risk factors center on Corporate GAAP gross margin, Altman-Z, and Form 4 insider metrics are N/A for ETF fund structures and Underlying index basket remains sensitive to Federal Reserve liquidity and Treasury yield swings.. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
🛡️ Portfolio Crash X-Ray
EXT / AFTER-HRS: $77.89 (-1.35%)🧬 ETF Open-End Share Creation/Redemption⚙️ Cash Engine: 16/20 (B+) • Liquid Basket
Verify 90D Bucket Audit →
📊 Historical Track Record: Scores of 53/100 (D+) historically posted market-perform odds over rolling 90-day windows (-0.9% avg 90D alpha vs SPY • 50.6% hit rate — wait for RQD ≥ 70 breakout).
Audit Bucket Track Record →
RQD QUANT TACHOMETERSELL / AVOID • D+
025507510053
JEV AI Jury Split (Battleground)
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D+ · Rk D+
Fund (16)Whales (9)Struct (13)Macro (9)Flow (6)
Each axis scored 0–20
12M PRICE TARGET CONE-2.3% Base Target
$100 Bull$77 Base$60 Bear
📬 FREE ARKK RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for ARKK)Realized 20D OHLCV Swing Band: ±6.2%
Deterministic 5-Pillar Attribution (53/100 Composite)
🔍 WHY ARKK SCORES 53/100 (D+) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: Cash Engine Quality+16/20 pts (30% of score)

ETF liquidity & tracking efficiency ($6.50B AUM)

▲ #2 Bullish Driver: SEC 10-K Forensic Risk+13/20 pts (25% of score)

Diversified basket structure mitigates single-issuer 10-K restatement risk

▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution6/20 pts (-14 pt drag)

ETF Open-End Share Creation/Redemption & executive Form 4 sales trim 14 pts from alignment

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)
61
Grade C$84.48+1.1% Next Q
Q2 (-2Q)
58
Grade C$85.42+0.8% Next Q
Q3 (-1Q)
56
Grade C$86.12-8.3% Next Q
Current
53
Grade D+$78.96-0.9% Hist 90D α
Trajectory: C (61) → D+ (53)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a ARKK Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While ARKK currently carries a cautious 53/100 (D+) rating due to Insider Conviction & Share Dilution (6/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Diversified Disruptive Growth & Biotech basket eliminates single-company earnings blowup risk.

🚀 Contrarian Squeeze Trigger #2

Deep intraday secondary-market liquidity with transparent underlying index holdings.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (ETF Open-End Share Creation/Redemption) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $ARKK• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “ARKK Beats Next Quarter EPS Consensus (Quarterly Rebalance / Distribution) & Holds Above 200D SMA”
YES 53%NO 47%Trade / Inspect Odds →
RSI-14 MOMENTUMNEUTRAL RANGE
37.230 Oversold · 70 Hot
ALTMAN-Z SHIELDETF / Index Composite — N/A for Fund Structure
N/A (ETF)Fund Structure
PIOTROSKI F-SCOREETF / Index Composite — N/A for Fund Structure
N/A (ETF)Fund Structure
52-WEEK LASER RANGE50% OF RANGE
L: $63$78.96H: $95
1. Basket Liquidity & Structure● HEALTHY
ETF / Index composite efficiency

ETF / Index Composite — N/A for corporate GAAP gross margins; reflects underlying basket liquidity and structure.

Factor Grade: B+RQD 16 / 20
2. Institutional Basket Flow● TRIMMING
13F & index options positioning

Tracks institutional 13F ETF basket allocations and index options positioning (corporate CEO Form 4 rules N/A for fund structure).

Factor Grade: D-RQD 15 / 40
3. Hidden Risks & Market Weather● WATCH
Macro regime & rate sensitivity

Evaluates index basket sensitivity to Federal Reserve liquidity and Treasury yield shifts (corporate 10-K Altman-Z / Piotroski checks N/A for ETF structure).

Factor Grade: D+RQD 22 / 40
MULTI-MODEL JEV QUANT JURY DELIBERATION

JEV AI Jury Split (Battleground) on ARKK

Cash & Moat Bull AI
Index Basket & Yield Model
BULLISH (80)

ETF / Index Composite — N/A for Fund Structure (single-company ROIC and GAAP gross margin do not apply to index funds).

SEC Forensic Auditor AI
Fund Structure & Liquidity Guard
NEUTRAL (65)

ETF / Index Composite — N/A for Fund Structure (corporate Altman-Z and Piotroski 9-point checks do not apply to ETFs).

Whale & Macro Hawk AI
Options Skew, 13F & Fed NetLiq
BEARISH (40)

15/40 institutional & smart-money positioning score with 9/20 macro alignment.

Bull Case: Why Buyers Like ARKK
  • ✓Diversified Disruptive Growth & Biotech basket eliminates single-company earnings blowup risk.
  • ✓Deep intraday secondary-market liquidity with transparent underlying index holdings.
Bear Case: What Could Go Wrong
  • !Corporate GAAP gross margin, Altman-Z, and Form 4 insider metrics are N/A for ETF fund structures.
  • !Underlying index basket remains sensitive to Federal Reserve liquidity and Treasury yield swings.
  • !Broad market drawdowns affect index vehicles in lockstep with constituent weights.
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring ARKK)

  • ✓Walkthrough of ARKK's RQD Radar, SEC cash-conversion gap & downside invalidation levels
  • ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
  • ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
Join Founding VIP Waitlist (No Card Required) →$100K Arena
ARKK // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +0.93%📐 HORIZONTAL RANGE
2026-11-03O $84.18H $84.18L $78.96C $78.96VOL 7.08M
RES: $97.73SUP: $65.78SMA50: $85.97SMA200: $78.28
$96.57$89.34$82.11$74.88$67.65RES $97.73SUP $65.78$78.962026-05-042026-06-182026-08-052026-09-212026-11-03
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

ARKK Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 ARKK Butterfly Map → + Track ARKK →
Share Count & Dilution Monitor

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle
ETF / Index Composite — N/A for Fund Structure

Single-issuer corporate Reverse-DCF growth hurdles do not apply to index funds or ETFs.

Ellis Vennor Setup Ledger

No active Ellis Vennor swing setup published on ARKK today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for ARKK. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for ARKK today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (ARKK)

ETF / Index Rank #26 of 40 ⚔️ ITA vs ARKK Full Matrix →

1. Head-to-Head ETF / Index Peer Comparison (ARKK vs. ITA, XLB, XBI, XLRE)

Industry: Disruptive Growth & Biotech (1 Tracked Issuers)

Across 40 tracked ETF / Index securities in the Roarable RQD universe, ARK Innovation ETF (ARKK) ranks #26 by composite RQD confidence (53/100, grade D+) and #33 by equity capitalization ($6.50B). Within this direct 5-issuer industry benchmark cohort, ARKK leads on earnings valuation at N/A trailing P/E, while ARKK leads on capital efficiency and profitability with ETF composite structure and benchmark tracking. XLB currently holds the highest overall quantitative score in the immediate peer group at 67/100 (C+) compared with ARKK at 53/100 (D+).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
ARKK ACTIVE
ARK Innovation ETF
D+ 53/100 — — — -6.46% $6.50B Benchmark Subject
ITA
iShares U.S. Aerospace & Defense ETF
D 47/100 — — — -2.17% $6.80B /ita-vs-arkk →
XLB
Materials Select Sector SPDR Fund
C+ 67/100 — — — +0.40% $6.00B /xlb-vs-arkk →
XBI
SPDR S&P Biotech ETF
C 65/100 — — — -1.16% $7.40B /xbi-vs-arkk →
XLRE
Real Estate Select Sector SPDR Fund
C 63/100 — — — +0.25% $8.00B /xlre-vs-arkk →

2. ARKK ETF Structure, Technical Regime & Benchmark Role Breakdown

EXCHANGE-TRADED FUND / COMPOSITE VEHICLE • NYSE

Because ARK Innovation ETF (ARKK) is structured as an exchange-traded fund / composite basket rather than a single operating corporation filing 10-K GAAP income statements, Roarable evaluates ARKK on technical trend regime, moving-average dispersion, 52-week range positioning, relative strength (RSI-14), and secondary-market share volume liquidity. At $78.96, ARKK trades vs. its 50-day SMA of $85.97 and 200-day SMA of $78.28 on daily liquidity of 7,079,972 shares.

50D SMA Level
$85.97
Medium-Term Trend Anchor
200D SMA Level
$78.28
Institutional Secular Line
52-Week Range Pos
50.0%
$62.94 – $94.82
RSI-14 Momentum
37.2
NEUTRAL RANGE
Volume Liquidity
7,079,972
AUM Cap $6.50B

3. ARKK Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is ARKK stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-03, ARK Innovation ETF (NYSE: ARKK) is rated D+ (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 53/100 at a spot price of $78.96 (-6.46% 1D, market cap $6.50B). Pillar breakdown: Fundamental Cash Engine 16/20, Institutional 13F & Options Flow 9/20, SEC Balance-Sheet Forensics 13/20, FRED Macro Regime Fit 9/20, and Executive Insider Alignment 6/20. Across 40 tracked ETF / Index issuers, ARKK ranks #26 in composite RQD confidence.

How does ARKK compare to ITA and XLB in the ETF / Index sector?

Within the ETF / Index sector (Disruptive Growth & Biotech), ARKK carries a Roarable D+ (53/100 RQD), trailing P/E of N/A, gross margin of N/A (ETF), and ROIC of N/A (ETF). By comparison, ITA (iShares U.S. Aerospace & Defense ETF) holds a D grade (47/100 RQD, P/E N/A, ROIC —, cap $6.80B) and XLB (Materials Select Sector SPDR Fund) posts a C+ grade (67/100 RQD, P/E N/A, ROIC —, cap $6.00B). Among the 5-stock peer group, ARKK leads on earnings multiple (N/A) while ARKK leads on capital efficiency (— ROIC).

What are the biggest fundamental strengths and SEC risk factors for ARKK?

For ARK Innovation ETF (ARKK), key quantitative strengths include Diversified Disruptive Growth & Biotech basket eliminates single-company earnings blowup risk and Deep intraday secondary-market liquidity with transparent underlying index holdings., while primary risk factors center on Corporate GAAP gross margin, Altman-Z, and Form 4 insider metrics are N/A for ETF fund structures and Underlying index basket remains sensitive to Federal Reserve liquidity and Treasury yield swings.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is ARKK trading relative to its 50-day, 200-day, and 52-week technical levels?

ARKK last traded at $78.96 (-6.46% on volume of 7,079,972 shares), positioning the stock -8.15% below its 50-day simple moving average ($85.97) and +0.87% above its 200-day simple moving average ($78.28). Across its 52-week range of $62.94 to $94.82, ARKK sits at the 50.3% percentile with a 14-day RSI of 37.2 (NEUTRAL RANGE) and an implied next-earnings move of ±6.2% ($74.06 to $83.86).

Direct Sub-Reports: ARKK RQD Cockpit ARKK 12M Forecast ARKK Earnings & Move ARKK Dividends & DRIP ARKK Insiders & 13F ARKK Whale Options ARKK Profit Sankey ARKK News & Why
ROARABLE RATING BRIEF • RQD 53/100 (D+) ✓ SEC XBRL & RQD VERIFIED

ARKK — ARK Innovation ETF: What the Facts Mean to a Prospective Investor

Methodology: RQD v6.2 Deterministic 5-Pillar & SEC XBRL Audit
Updated: 2026-11-03

1. Roarable Rating Brief: What This Means to a Prospective Investor

ARK Innovation ETF (ARKK) earns a live Roarable RQD composite score of 53/100, corresponding to a D+ letter grade (Roarable Sell) at a spot price of $78.96 (-6.46% 1D, market capitalization $6.50B).

  • Fundamental Cash Engine (16/20): Anchored by return on invested capital (ROIC) of —, gross margin of —, operating margin of —, and free cash flow yield of —.
  • Whale 13F & Options Flow (9/20) + Insider Conviction (6/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
  • Macro Regime Fit (9/20) + Forensic Balance Sheet (13/20): Incorporates a 1.00x equity beta, Altman Z-Score of N/A, Piotroski F-Score of N/A, and Debt/Equity of N/A.

2. Business Model, Unit Margins & SEC Financial Trajectory

ARK Innovation ETF is an exchange-traded fund classified in the ETF / Index sector and the Disruptive Growth & Biotech industry, listed on the NYSE..5B in assets under management.

3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff

  • 🐂 Primary Bull Case (D+ • RQD 53/100): Diversified Disruptive Growth & Biotech basket eliminates single-company earnings blowup risk. Deep intraday secondary-market liquidity with transparent underlying index holdings. With Fundamental Cash Engine at 16/20 and Institutional Whale Flow at 9/20, sustained execution supports upside toward the upper end of the $62.94 – $94.82 52-week range.
  • 🐻 Primary Bear Case & Valuation Risk: Corporate GAAP gross margin, Altman-Z, and Form 4 insider metrics are N/A for ETF fund structures. Investors must weigh current valuation against — operating margins and a 1.00x macro beta.

4. 2nd-Order Butterfly Ripples & Key Questions to Watch

The supply chain is reported as NONE, with an empty list of butterfly links and no proprietary signals. The source data therefore does not establish upstream or downstream dependencies for ARKK. Sector correlations and second-order bottlenecks cannot be derived from the provided sources. The news feed references individual holdings (such as Tesla, AMD, NVDA, PLTR, and biotech names), and any ripple effects from those names would depend on information not contained in these sources.

  • Key Question #1: Can ARKK sustain or expand its — operating margin and — ROIC against Disruptive Growth & Biotech peers over the next 4 quarters?
  • Key Question #2: Will free cash flow conversion (— FCF yield) strengthen balance-sheet liquidity (Altman Z-Score N/A) toward the $94.82 52-week high?
  • Key Question #3: How sensitive is ARKK's equity valuation to ETF / Index capital spending cycles and macro interest-rate shifts (Beta 1.00x)?

ARKK Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for ARK Innovation ETF (ARKK) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to ARKK Debate Forum (3) ↓
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

ARKK Bull vs. Bear Conversation Board — What's Your Call at $78.96?

🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON ARKK 🐻 33% BEARISH CONVICTION
1. Pick Your Side on ARKK:
💡 Tip: Back up your call with a price target or RQD metric to get upvoted to the top.
TA TapeReader_Pro RQD DEBATE OPENER • Price Action & Volume Trader 🐂 BULLISH 🎯 Target: $93.17 (+18.0%)
📌 Pinned Debate

Balance-sheet pillar scores 13/20 with a Piotroski F-Score of 6/9 and Altman Z of 2.5, and recent feed items report new capital deploye

Here is why I am bullish on ARKK here at $78.96: Balance-sheet pillar scores 13/20 with a Piotroski F-Score of 6/9 and Altman Z of 2.5, and recent feed items report new capital deployed into select positions.. Compare ARKK's 0.0% operating margin and 0.0% ROIC against the rest of Disruptive Growth & Biotech. As long as cash conversion holds up, dips toward $75.01 are getting bought.

VolSurface_Trader 🐂 BULL

Both sides have a point here — ARKK's 13/20 balance sheet score keeps downside contained, so the real swing factor next earnings call is backlog and FCF conversion.

FA FadeTheHype RQD DEBATE OPENER • Contrarian Tape Reader 🐻 BEARISH 🎯 Target: $63.96 (-19.0%)
Spot @ $78.96

Cash-engine pillar scores 17/20 with ROIC and FCF yield both at 0%, and insider conviction scores only 7/20.

Sitting on the sidelines or leaning short ARKK above $78.96. Cash-engine pillar scores 17/20 with ROIC and FCF yield both at 0%, and insider conviction scores only 7/20.. Until Fundamental Cash Engine (16/20) and FCF yield (0.0%) inflect higher, upside is capped near $94.82.

LIVE TAPE SPY $752.10 -1.80% QQQ $681.09 -3.60% DIA $519.34 -1.08% IWM $279.14 -1.68% NVDA $202.06 -1.26% AAPL $338.32 -1.83% MSFT $507.12 -2.83% TSLA $403.82 +1.00% PLTR $178.34 -3.13% SOFI $16.60 -0.95% IBIT $43.35 -5.42% GLD $361.65 -3.59%